Kaptoge S, Armbrecht G, Felsenberg D, Lunt M, O’Neill TW, Silman AJ, Reeve J (2004) When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 19:1982–1993CrossRefPubMed 17. Naganathan V, Jones G, Nash P, Nicholson G, Eisman J, Sambrook PN (2000) Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to
age, bone density, and corticosteroid use. Arch Intern Med 160:2917–2922CrossRefPubMed 18. van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787CrossRefPubMed 19. Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S, Giorgino www.selleckchem.com/products/epacadostat-incb024360.html R, Moro L, Giustina A (2006) High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39:253–259CrossRefPubMed 20. Kanis J (2008) FRAX WHO Fracture Risk Assessment Tool. http://www.shef.ac.uk/FRAX/ 21. Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative ACP-196 research buy technique. J Bone Miner Res 8:1137–1148CrossRefPubMed
22. Vokes T, Bachman D, Baim S, find more Binkley N, Broy S, Ferrar L, Lewiecki EM, Richmond B, Schousboe J (2006) Vertebral fracture assessment: the 2005 ISCD Official Positions. J Clin Densitom 9:37–46CrossRefPubMed 23. Delmas PD, Genant HK, Crans GG, Stock JL, Wong M, Siris E, Adachi JD (2003) Severity of prevalent vertebral fractures and the risk of subsequent
vertebral and nonvertebral fractures: results from the MORE trial. Bone 33:522–532CrossRefPubMed 24. Binkley N, Krueger D, Gangnon R, Genant HK, Drezner MK (2005) Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures. Osteoporos Int 16:1513–1518CrossRefPubMed 25. (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced FER Osteoporosis. Arthritis Rheum 44:1496-1503. 26. Hans D, Downs RW Jr, Duboeuf F, Greenspan S, Jankowski LG, Kiebzak GM, Petak SM (2006) Skeletal sites for osteoporosis diagnosis: the 2005 ISCD Official Positions. J Clin Densitom 9:15–21CrossRefPubMed 27. STATA (2003) Stata Statistical Software, Release 10.0. STATA, College Station 28. Little R, Rubin, D (2002) Statistical analysis with missing data. Wiley, New York. 29. Agresti A (1996) Categorical data analysis. Wiley-Interscience, New York. 30. (2008) National Osteoporosis Foundation: Clinician’s Guide to Prevention and treatment of Osteoporosis. http://www.nof.org/professionals/NOF_Clinicians%20_Guide.pdf. 31. 2007 ISCD Official Positions. http://www.iscd.org/Visitors/positions/OfficialPositions 32.
Related posts:
- cfm#MP_2583 [Accessed 1 July 2011] 49 Borgstrom F, Strom O, K
- Vertebroplasty does not play a role in further fracture preventio
- Therefore, a part of vertebral fractures identified after 6 month
- 79 (1 6, 2 0) 3 13 (2 7, 3 7) Likelihood ratio (−) 0 16 (0 09, 0
- e , maintained a medical possession ratio to initiated therapy of